Kaplan & Sadock’s Synopsis of Psychiatry 12th Edition by Robert Boland, ISBN-13: 978-1975145569

Description

Kaplan & Sadock’s Synopsis of Psychiatry 12th Edition by Robert Boland, ISBN-13: 978-1975145569

[PDF eBook eTextbook]

• Publisher: ‎ LWW; Twelfth, North American edition (April 22, 2021)
• Language: ‎ English
• 1173 pages
• ISBN-10: ‎ 1975145569
• ISBN-13: ‎ 978-1975145569

Selected as a Doody’s Core Title for 2022 and 2023!

Accurate, reliable, objective, and comprehensive, Kaplan & Sadock’s Synopsis of Psychiatry has long been the leading clinical psychiatric resource for clinicians, residents, students, and other health care professionals both in the US and worldwide. Now led by a new editorial team of Drs. Robert Boland and Marcia L. Verduin, it continues to offer a trusted overview of the entire field of psychiatry while bringing you up to date with current information on key topics and developments in this complex specialty. The twelfth edition has been completely reorganized to make it more useful and easier to navigate in today’s busy clinical settings.

– A revised table of contents moves the most clinically relevant material to the beginning of the book, including sections on diagnosis, psychopathology and psychiatric conditions, treatment across the lifespan, and therapy and other interventions.

– Reformats clinical chapters to include clearer section headings and easy-to-digest summaries of important information, all with the goal of helping you find information quickly and easily locate answers to specific problems.

– Includes numerous case studies to enhance the learning experience.

– Presents the most current treatment methods including descriptions of all modern psychotherapeutic techniques.

– Includes descriptive tables for all relevant DSM-5 and ICD-10 diagnoses and an up-to-date psychopharmacology section organized according to mechanisms of action.

– Carries on the tradition of excellence established by Drs. Benjamin J. Sadock and Virginia A. Sadock, with Dr. Pedro Ruiz returning as Consulting Editor.

Table of Contents:

Cover

Title Page

Copyright

Dedication

Preface

Contents

A Clinical Psychiatry

1. Examination and Diagnosis of the Psychiatric Patient

1.1 The Adult Patient

PSYCHIATRIC INTERVIEW, HISTORY, AND MENTAL STATUS EXAMINATION

PHYSICAL EXAMINATION OF THE PSYCHIATRIC PATIENT

THE PSYCHIATRIC REPORT AND MEDICAL RECORD

PSYCHIATRIC RATING SCALES

CLINICAL NEUROPSYCHOLOGY AND INTELLECTUAL ASSESSMENT OF ADULTS

PERSONALITY ASSESSMENT: ADULTS AND CHILDREN

MEDICAL ASSESSMENT AND LABORATORY TESTING IN PSYCHIATRY

NEUROIMAGING

1.2 Children and Adolescents

CLINICAL INTERVIEWS

DIAGNOSTIC INSTRUMENTS

QUESTIONNAIRES AND RATING SCALES

COMPONENTS OF THE CHILD PSYCHIATRIC EVALUATION

RECOMMENDATIONS AND TREATMENT PLAN

INTELLECTUAL DISABILITY PSYCHIATRIC INTERVIEW AND TESTS

1.3 Geriatric Patients

PSYCHIATRIC EXAMINATION OF THE OLDER PATIENT

EARLY DETECTION AND PREVENTION STRATEGIES

2. Neurodevelopmental Disorders and Other Childhood Disorders

2.1 Intellectual Disability

NOMENCLATURE

CLASSIFICATION

DEGREES OF SEVERITY OF INTELLECTUAL DISABILITY

CLINICAL FEATURES

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.2 Communication Disorders

LANGUAGE DISORDER

SPEECH SOUND DISORDER

CHILD-ONSET FLUENCY DISORDER (STUTTERING)

SOCIAL (PRAGMATIC) COMMUNICATION DISORDER

UNSPECIFIED COMMUNICATION DISORDER

2.3 Autism Spectrum Disorder

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY AND PATHOGENESIS

2.4 Attention-Deficit/Hyperactivity Disorder

CLINICAL FEATURES

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

ADULT MANIFESTATIONS OF ADHD

2.5 Specific Learning Disorder

SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN READING

SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN MATHEMATICS

SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN WRITTEN EXPRESSION

2.6 Motor Disorders

DEVELOPMENTAL COORDINATION DISORDER

STEREOTYPIC MOVEMENT DISORDER

TOURETTES DISORDER

PERSISTENT (CHRONIC) MOTOR OR VOCAL TIC DISORDER

2.7 Feeding and Eating Disorders of Infancy or Early Childhood

PICA

RUMINATION DISORDER

AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER

2.8 Trauma- and Stressor-Related Disorders in Children

REACTIVE ATTACHMENT DISORDER AND DISINHIBITED SOCIAL ENGAGEMENT DISORDER

POSTTRAUMATIC STRESS DISORDER OF INFANCY, CHILDHOOD, AND ADOLESCENCE

2.9 Depressive Disorders and Suicide in Children and Adolescents

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

SUICIDE

2.10 Early-Onset Bipolar Disorder

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.11 Disruptive Mood Dysregulation Disorder

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

2.12 Disruptive Behaviors of Childhood

OPPOSITIONAL DEFIANT DISORDER

CONDUCT DISORDER

2.13 Anxiety Disorders of Infancy, Childhood, and Adolescence: Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia)

SEPARATION ANXIETY DISORDER

GENERALIZED ANXIETY DISORDER

SOCIAL ANXIETY DISORDER (SOCIAL PHOBIA)

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.14 Selective Mutism

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.15 Obsessive-Compulsive Disorder in Childhood and Adolescence

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.16 Early-Onset Schizophrenia

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

ATTENUATED PSYCHOSIS SYNDROME

2.17 Adolescent Substance Use Disorders

DIAGNOSIS AND CLINICAL FEATURES

COMORBIDITY

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3. Neurocognitive Disorders

3.1 Delirium

DIAGNOSIS AND CLINICAL FEATURES

PHYSICAL AND LABORATORY EXAMINATIONS

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3.2 Dementia (Major Neurocognitive Disorder)

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3.3 Major or Minor Neurocognitive Disorder due to Another Medical Condition (Amnestic Disorders)

DIAGNOSIS

CLINICAL FEATURES AND SUBTYPES

PATHOLOGY AND LABORATORY EXAMINATION

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3.4 Neurocognitive and Other Psychiatric Disorders due to a General Medical Condition

SPECIFIC DISORDERS

3.5 Mild Cognitive Impairment

DEFINITION

CLINICAL PRESENTATION

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY AND ETIOLOGY OF MCI

4. Substance Use and Addictive Disorders

4.1 General Features of the Substance-Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

COMORBIDITY

TREATMENT APPROACH

ETIOLOGY

4.2 Alcohol-Related Disorders

DIAGNOSIS AND CLINICAL FEATURES

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT OF ALCOHOL USE DISORDERS

PATHOLOGY

ETIOLOGY

4.3 Cannabis-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

COMORBIDITY

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

4.4 Opioid-Related Disorders

CLINICAL FEATURES

COMORBIDITY

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

ETIOLOGY

4.5 Sedative-, Hypnotic-, or Anxiolytic-Related Disorders

DIAGNOSIS

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

4.6 Stimulant-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

COMORBIDITY

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

ETIOLOGY

4.7 Tobacco-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

PATHOLOGY

4.8 Caffeine-Related Disorders

CLINICAL FEATURES AND DIAGNOSIS

COMORBIDITY

TREATMENT

EPIDEMIOLOGY

PATHOLOGY AND ETIOLOGY

4.9 Hallucinogen-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

PATHOLOGY

4.10 Inhalant-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

4.11 Anabolic-Androgenic Steroid Use

CLINICAL FEATURES AND DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

PATHOLOGY

ETIOLOGY

4.12 Gambling Disorder

CLINICAL FEATURES

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

4.13 Other Disorders Related to the Addictive Disorders

INTERNET GAMING DISORDER

MOBILE OR CELL PHONE COMPULSION

REPETITIVE SELF-MUTILATION

COMPULSIVE SEXUAL BEHAVIOR

5. Schizophrenia Spectrum and Other Psychotic Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

OBJECTIVE TESTS FOR THE DISORDER

DIFFERENTIAL DIAGNOSIS FOR PSYCHOTIC DISORDERS

COMORBIDITY

COURSE

PROGNOSIS

TREATMENT APPROACH

THE EPIDEMIOLOGY OF THE DISORDERS

THE NEUROBIOLOGY OF THE DISORDER

THE PSYCHOLOGY OF THE DISORDER

ETIOLOGY

6. Bipolar Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE

PROGNOSIS

TREATMENT APPROACH

THE EPIDEMIOLOGY OF THE DISORDER(S)

THE NEUROBIOLOGY OF THE DISORDER

THE PSYCHOLOGY OF THE DISORDER

ETIOLOGY

7. Depressive Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE

PROGNOSIS

TREATMENT APPROACH

THE EPIDEMIOLOGY OF DEPRESSION

THE NEUROBIOLOGY OF DEPRESSION

THE PSYCHOLOGY OF DEPRESSION

ETIOLOGY

8. Anxiety Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE

TREATMENT APPROACH

THE EPIDEMIOLOGY OF THE DISORDER(S)

THE NEUROBIOLOGY OF THE DISORDER

ETIOLOGY

9. Obsessive-Compulsive and Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

10. Trauma- and Stressor-Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS FOR THE TRAUMA- AND STRESSOR-RELATED DISORDERS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

11. Dissociative Disorders

DIAGNOSTIC AND CLINICAL FEATURES

DEPERSONALIZATION/DEREALIZATION DISORDER

DISSOCIATIVE IDENTITY DISORDER

OTHER SPECIFIED OR UNSPECIFIED DISSOCIATIVE DISORDER

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

12. Somatic Symptom and Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

EVALUATION OF SOMATIC SYMPTOM AND RELATED DISORDERS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT OF SOMATIC SYMPTOM AND RELATED DISORDERS

EPIDEMIOLOGY

ETIOLOGY

13. Feeding and Eating Disorders

CLINICAL FEATURES

DIAGNOSIS AND CLINICAL FEATURES

PATHOLOGY AND LABORATORY EXAMINATION

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

14. Elimination Disorders

ENCOPRESIS

ENURESIS

15. Sleep–Wake Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

CLINICAL TOOLS IN SLEEP MEDICINE

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

TREATMENT APPROACH

16. Human Sexuality and Sexual Dysfunctions

SEXUAL DYSFUNCTIONS

PARAPHILIC DISORDERS

SEX ADDICTION AND COMPULSIVITY

NORMAL SEXUALITY

17. Gender Dysphoria, Gender Identity, and Related Conditions

INTRODUCTION

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

COMORBIDITY

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

18. Disruptive, Impulse-Control, and Conduct Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

OBJECTIVE TESTS FOR THE DISORDERS

DIFFERENTIAL DIAGNOSIS FOR THE DISRUPTIVE AND IMPULSE-CONTROL DISORDERS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

19. Personality Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

20. Other Conditions that May be a Focus of Clinical Attention

INTRODUCTION

MALINGERING

BEREAVEMENT

OCCUPATIONAL PROBLEMS

ADULT ANTISOCIAL BEHAVIOR

RELIGIOUS OR SPIRITUAL PROBLEM

ACCULTURATION PROBLEM

PHASE OF LIFE PROBLEM

NONCOMPLIANCE WITH TREATMENT

RELATIONAL PROBLEMS

B Treatment Across the Lifespan

21. Psychopharmacology

21.1 Antipsychotics

SEROTONIN–DOPAMINE ANTAGONISTS AND SIMILARLY ACTING DRUGS (SECOND-GENERATION OR ATYPICAL ANTIPSYCHOTICS)

DOPAMINE RECEPTOR ANTAGONISTS (FIRST-GENERATION ANTIPSYCHOTICS)

21.2 Antidepressants

SELECTIVE SEROTONIN REUPTAKE INHIBITORS

SELECTIVE SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS

BUPROPION

MIRTAZAPINE

NEFAZODONE AND TRAZODONE

TRICYCLICS AND TETRACYCLICS

MONOAMINE OXIDASE INHIBITORS

THYROID HORMONES

NOVEL AGENTS

21.3 Mood Stabilizers

LITHIUM

VALPROATE

LAMOTRIGINE

CARBAMAZEPINE AND OXCARBAZEPINE

OTHER ANTICONVULSANTS

CALCIUM CHANNEL BLOCKERS

21.4 Anxiolytics

BENZODIAZEPINES AND DRUGS ACTING ON GABA RECEPTORS

BUSPIRONE

β-ADRENERGIC RECEPTOR ANTAGONISTS

BARBITURATES AND SIMILARLY ACTING DRUGS

21.5 Drugs Used to Treat Sleep Disorders

NONBENZODIAZEPINE GABA AGONISTS

MELATONIN AGONISTS: RAMELTEON AND MELATONIN

PRAZOSIN

21.6 Stimulants

STIMULANT DRUGS AND ATOMOXETINE

ATOMOXETINE (STRATTERA)

21.7 Drugs Used to Treat Substance Use Disorders

OPIOID RECEPTOR AGONISTS

OPIOID RECEPTOR ANTAGONISTS: NALTREXONE, NALMEFENE, AND NALOXONE

DISULFIRAM AND ACAMPROSATE

CLONIDINE AND GUANFACINE

21.8 Drugs Used for Cognitive Enhancement

CHOLINESTERASE INHIBITORS

MEMANTINE

21.9 Drugs Used to Treat Sexual Disorders

PHOSPHODIESTERASE-5 INHIBITORS

YOHIMBINE

21.10 Drugs Used to Treat the Side Effects of Psychotropic Drugs

ANTICHOLINERGIC AGENTS

ANTIHISTAMINES

DOPAMINE RECEPTOR AGONISTS AND PRECURSORS

DRUGS TO TREAT PSYCHOTROPIC-INDUCED WEIGHT GAIN

21.11 Nutritional Supplements and Related

NUTRITIONAL SUPPLEMENTS AND MEDICAL FOODS

PHYTOMEDICINES

22. Other Somatic Therapies

ELECTROCONVULSIVE THERAPY

OTHER BRAIN STIMULATION METHODS

NEUROSURGICAL TREATMENTS AND DEEP BRAIN STIMULATION

23. Psychotherapy

PSYCHOANALYSIS AND PSYCHOANALYTIC PSYCHOTHERAPY

BRIEF PSYCHODYNAMIC PSYCHOTHERAPY

GROUP PSYCHOTHERAPY, COMBINED INDIVIDUAL AND GROUP PSYCHOTHERAPY, AND PSYCHODRAMA

FAMILY THERAPY AND COUPLES THERAPY

DIALECTICAL BEHAVIOR THERAPY

BIOFEEDBACK

COGNITIVE THERAPY

BEHAVIOR THERAPY

HYPNOSIS

INTERPERSONAL THERAPY

NARRATIVE PSYCHOTHERAPY

COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY

MENTALIZATION-BASED TREATMENT

PSYCHOEDUCATIONAL INTERVENTIONS

24. Psychiatric Rehabilitation and Other Interventions

PSYCHIATRIC REHABILITATION

GENETIC COUNSELING

25. Consultation to Other Disciplines

25.1 Consultation-Liaison Psychiatry

HISTORY

CURRENT TRENDS

EVALUATION PROCESS IN PSYCHOSOMATIC MEDICINE

TREATMENTS USED IN PSYCHOSOMATIC MEDICINE

PSYCHO-ONCOLOGY

25.2 Geriatric Psychiatry

PSYCHIATRIC PROBLEMS OF OLDER PERSONS

MENTAL DISORDERS OF OLD AGE

SUICIDE RISK

OTHER CONDITIONS OF OLD AGE

SPOUSAL BEREAVEMENT

PSYCHOPHARMACOLOGICAL TREATMENT OF GERIATRIC DISORDERS

PSYCHOTHERAPY FOR GERIATRIC PATIENTS

25.3 Psychiatric Emergencies

TREATMENT SETTINGS

EPIDEMIOLOGY

EVALUATION

SPECIFIC INTERVIEW SITUATIONS

TREATMENT OF EMERGENCIES

PSYCHIATRIC EMERGENCIES IN CHILDREN

26. Level of Care

INPATIENT ADMISSION

PARTIAL HOSPITAL TREATMENT

INTENSIVE OUTPATIENT TREATMENT

OUTPATIENT CARE

RESIDENTIAL CARE

C Other Issues Relevant to Psychiatry

27. Ethics and Professionalism

PROFESSIONAL CODES

BASIC ETHICAL PRINCIPLES

SPECIFIC ISSUES

28. Forensic and Legal Issues

MEDICAL MALPRACTICE

PRIVILEGE AND CONFIDENTIALITY

HIGH-RISK CLINICAL SITUATIONS

HOSPITALIZATION

RIGHT TO TREATMENT

RIGHT TO REFUSE TREATMENT

CIVIL RIGHTS OF PATIENTS

SECLUSION AND RESTRAINT

INFORMED CONSENT

CHILD CUSTODY

TESTAMENTARY AND CONTRACTUAL CAPACITY AND COMPETENCE

CRIMINAL LAW

OTHER AREAS OF FORENSIC PSYCHIATRY

29. End-of-Life Issues and Palliative Care

29.1 Death, Dying, and Bereavement

DEATH AND DYING

BEREAVEMENT, GRIEF, AND MOURNING

LIFE CYCLE PERSPECTIVES ABOUT BEREAVEMENT

29.2 Palliative Care

PREVALENCE

GENERAL TREATMENT PRINCIPLES

ANXIETY IN PATIENTS WITH ADVANCED DISEASE

DEPRESSION IN PATIENTS WITH ADVANCED DISEASE

CONFUSIONAL STATES IN PATIENTS WITH ADVANCED DISEASE

DISEASE-SPECIFIC CONSIDERATIONS

PATIENT–FAMILY UNIT

DECISION POINTS, ADVANCE DIRECTIVES, PROXIES, AND SURROGATES

CARING FOR THE DYING PATIENT

COMMUNICATION

TERMINAL CARE DECISIONS

CARING FOR THE FAMILY

PALLIATIVE CARE

PAIN MANAGEMENT

PALLIATION OF OTHER SYMPTOMS

HOSPICE CARE

NEONATAL AND INFANT END-OF-LIFE CARE

CHILD END-OF-LIFE CARE

SPIRITUAL ISSUES

ALTERNATIVE AND COMPLEMENTARY MEDICINE

29.3 Euthanasia and Physician-Assisted Suicide

EUTHANASIA

PHYSICIAN-ASSISTED SUICIDE

FUTURE DIRECTIONS

30. Community Psychiatry

INTRODUCTION

CONTEMPORARY PUBLIC AND COMMUNITY PSYCHIATRY

THE ROLE OF PUBLIC AND COMMUNITY PSYCHIATRY IN TWENTY-FIRST CENTURY HEALTH CARE

31. Global and Cultural Issues in Psychiatry

PREVALENCE AND BURDEN OF MENTAL DISORDERS WORLDWIDE

TREATMENT GAP AND PROJECTED POPULATION-LEVEL TREATMENT EFFECTIVENESS WORLDWIDE

RESOURCES FOR MENTAL HEALTH CARE WORLDWIDE

PRINCIPLES FOR MENTAL HEALTH PROGRAM DEVELOPMENT AND BARRIERS TO CHANGE WORLDWIDE

STIGMATIZING ATTITUDES TOWARD PEOPLE WITH MENTAL DISORDERS

RELATIONSHIPS BETWEEN MENTAL AND PHYSICAL DISEASES

ETHICAL ISSUES IN MENTAL HEALTH CARE

INTERNATIONAL ORGANIZATIONS ACTIVE IN THE MENTAL HEALTH FIELD

FUTURE PERSPECTIVES

D Contributions from the Sciences and Social Sciences to Psychiatry

32. Normal Development and Aging

32.1 Infant, Child, and Adolescent Development

PRENATAL, INFANT, AND CHILD

PRENATAL

INFANCY

TODDLER PERIOD

PRESCHOOL PERIOD

MIDDLE YEARS

ADOLESCENCE

32.2 Adulthood

INTRODUCTION

YOUNG ADULTHOOD (20 TO 40 YEARS OF AGE)

MIDDLE ADULTHOOD (40 TO 65 YEARS OF AGE)

DIVORCE

ADULT MATURITY

32.3 Old Age

DEMOGRAPHICS

BIOLOGY OF AGING

STAGE THEORIES OF PERSONALITY DEVELOPMENT

PSYCHOSOCIAL ASPECTS OF AGING

33. Contributions from the Neurosciences

THE HUMAN BRAIN

FUNCTIONAL NEUROANATOMY

NEURAL DEVELOPMENT AND NEUROGENESIS

NEUROPHYSIOLOGY AND NEUROCHEMISTRY

PSYCHONEUROENDOCRINOLOGY

IMMUNE SYSTEM AND CENTRAL NERVOUS SYSTEM INTERACTIONS

NEUROGENETICS

APPLIED ELECTROPHYSIOLOGY

CHRONOBIOLOGY

34. Contributions from the Behavioral and Social Sciences

34.1 Contributions from the Psychosocial Sciences

JEAN PIAGET AND COGNITIVE DEVELOPMENT

ATTACHMENT THEORY

LEARNING THEORY

BIOLOGY OF MEMORY

MULTIPLE TYPES OF MEMORY

NEUROIMAGING AND MEMORY

SLEEP AND MEMORY

ASSESSMENT OF MEMORY FUNCTIONS

IMPLICATIONS

34.2 Normality and Mental Health

DEFINING MENTAL HEALTH

MODELS OF MENTAL HEALTH

34.3 Contributions from the Sociocultural Sciences

SOCIOBIOLOGY AND ETHOLOGY

TRANSCULTURAL PSYCHIATRY

CULTURE-BOUND SYNDROMES

34.4 Theories of Personality and Psychopathology

SIGMUND FREUD: FOUNDER OF CLASSIC PSYCHOANALYSIS

ERIK H. ERIKSON

OTHER PSYCHODYNAMIC SCHOOLS

POSITIVE PSYCHOLOGY

35. A Brief History of Psychiatry

PSYCHIATRY BEFORE THE MODERN ERA

PSYCHIATRY IN THE MODERN AGE

DEINSTITUTIONALIZATION

THE CLASSIFICATION OF PSYCHIATRIC DISORDERS

LOOKING TO THE FUTURE

Glossary of Terms Relating to Signs and Symptoms

Index

Dr. Marcia L. Verduin is the Associate Dean for Students and a Professor of Psychiatry at the University of Central Florida College of Medicine (UCF COM). She graduated from the University of Florida College of Medicine and completed her residency training and addiction psychiatry fellowship at the Medical University of South Carolina. She is a Fellow of the American College of Psychiatrists, and a Distinguished Fellow of both the American Psychiatric Association and the Association for Academic Psychiatry. Her clinical work is currently based at UCF Health, where she provides consultative services on an outpatient basis; she previously worked with Orlando’s veteran population in a residential rehabilitation unit at the Orlando VAMC. In 2007, Dr. Verduin became the first psychiatry faculty member at UCF’s new medical school, where she played an integral role in developing the overarching undergraduate medical education curriculum, establishing policies and procedures, hiring faculty and staff, and securing LCME accreditation.

Currently, Dr. Verduin serves as the Associate Dean for Students, a position she has held for more than a decade. In this role, she has focused her attention on growing the Student Affairs Office into a robust unit that oversees the areas of Admissions, Student Academic Support, Student Financial Services, Student Records, Student Services, and Student Counseling and Wellness. Her work in developing a strong career advising program for medical students gained national recognition as the sole recipient of the 2015 AAMC Excellence in Medical Student Career Advising Program Award.

In addition to her roles at UCF COM, Dr. Verduin serves as the Vice Chair for the American Board of Psychiatry and Neurology’s Addiction Psychiatry Article-Based Assessment Committee, as a member of the Accreditation Council for Graduate Medical Education Addiction Psychiatry Milestones 2.0 Work Group, and as the Book Editor for the Journal of Psychiatric Practice. Additionally, Dr. Verduin is currently serving as the Association of American Medical College’s Group on Student Affairs (GSA) representative to the National Board of Medical Examiners Advisory Committee for Medical School Programs. She is the Immediate Past Chair of the Southern GSA, a Past President of the Association of Academic Psychiatry and has served as a member of the Board of Regents for the American College of Psychiatrists.

What makes us different?

• Instant Download

• Always Competitive Pricing

• 100% Privacy

• FREE Sample Available

• 24-7 LIVE Customer Support